title: Drug points: Severe myalgia from an interaction between treatments with pantoprazole and methotrexate.
authors.affiliation: Institute of Clinical Pharmacology, Hospital of the Otto-von-Guericke-University, D-39120 Magdeburg, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Tröger
authors.forename: B
authors.initials: B
authors.lastname: Stötzel
authors.forename: J
authors.initials: J
authors.lastname: Martens-Lobenhoffer
authors.forename: H
authors.initials: H
authors.lastname: Gollnick
authors.forename: F P
authors.initials: FP
authors.lastname: Meyer
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D001471:Barrett Esophagus / Q000188:drug therapy; D001562:Benzimidazoles / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000009:adverse effects*; D004347:Drug Interactions; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced*; D009853:Omeprazole / Q000031:analogs & derivatives; D010146:Pain / Q000139:chemically induced*; D000077402:Pantoprazole; D013454:Sulfoxides / Q000009:adverse effects*
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D001562:Benzimidazoles; D003879:Dermatologic Agents; D013454:Sulfoxides; D000077402:Pantoprazole; D009853:Omeprazole; D008727:Methotrexate